Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Potential to improve the therapeutic situation of HCC patients – The influence of Regorafenib and Lenvatinib treatment in combination with Cdk5 inhibition in HCC

#2019

PMU Author
Petra Huber-Cantonati

All Authors
MA Ardelt, Petra Huber-Cantonati, J. Pachmayr

Abstract

We are sorry. The full text is not available.